Helix Biopharma Corp. Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Helix Biopharma Corp. in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
U****************
?
A****************
Kontra
?
M************
?
W******* i* V********
?
M****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Helix Biopharma Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Helix Biopharma Corp. | - | - | - | - | - | - | - |
| Resverlogix Corp | 6,30 % | 3,85 % | 21,62 % | 101,49 % | 150,00 % | -35,71 % | -87,84 % |
| Enwave Corporation | -4,46 % | -6,14 % | -15,08 % | 65,89 % | 55,07 % | -33,23 % | -73,87 % |
| Aurinia Pharmaceuticals Inc. | 0,70 % | 0,71 % | 0,75 % | 45,94 % | 54,63 % | 203,55 % | 12,92 % |
News
BioCardia Narrows Loss in Fiscal Q2
BioCardia (NASDAQ:BCDA), a clinical-stage cell therapy company focused on treatments for heart disease, released its financial results for the second quarter of 2025 on August 11, 2025. The company
Helix Energy Q2 Revenue Falls 17%
Helix Energy Solutions Group (NYSE:HLX), a diversified offshore energy services provider, reported weaker-than-expected Q2 2025 results, released on July 23, 2025. The headline was a disappointing